JM

Jyoti Malik

Active Director Director DIN 07847817
DIN 07847817 First appointment Jun 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2017
Shareholding value •••• Premium profile

About Jyoti Malik

Data last updated:

Jyoti Malik is a Director at Tirupati Pharmaceuticals Private Limited (since 2017). The company operates in Healthcare. Tirupati Pharmaceuticals Private Limited reported revenue of ₹73.1 Lakh (FY 2021).

DIN 07847817
Primary Designation Director
Industry Healthcare
First Appointment 01 Jun 2017
Oldest Company Age 17 yrs
Largest company Tirupati Pharmaceuticals Private Limited · ₹73.1 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20172009₹73.1 Lakh (FY 2021)Active

Board colleagues of Jyoti Malik

Directorship timeline

Open interactive timeline →
Tirupati Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyoti Malik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Malik

Jyoti Malik currently holds 1 directorship: Tirupati Pharmaceuticals Private Limited (Director, since 01 Jun 2017, revenue ₹73.1 Lakh (FY 2021)).

Jyoti Malik was first appointed on 01 Jun 2017 as Director at Tirupati Pharmaceuticals Private Limited.

The current boards of Jyoti Malik's companies include Anubhav Malik (Tirupati Pharmaceuticals Private Limited), Hemant Sachdeva (Tirupati Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available